Evidence map›Paper›PMID 41060389›Full record

Observational studyNaunyn-Schmiedeberg's archives of pharmacology2026

Associations of sphingosine-1-phosphate with soluble P-selectin and adverse clinical outcome in patients with cerebral ischemia with and without acetylsalicylic acid treatment.

Nils-Ole Gloyer, Eileen Moritz, Laura Schwieren, Ulrike Meyer, Götz Thomalla, Günter Daum, Tim Magnus, Rainer Böger, Chi-Un Choe, Bernhard H Rauch and 1 more

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Nils-Ole GloyerInstitute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Eileen MoritzDepartment of Pharmacology, University Medicine Greifswald, Greifswald, Germany.
Laura SchwierenInstitute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ulrike MeyerDepartment of Pharmacology and Toxicology, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Götz ThomallaDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Günter DaumGerman Center for Cardiovascular Research (DZHK e.V.) Partner Site, Hamburg/Kiel/Lübeck, Hamburg, Germany.
Tim MagnusDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rainer BögerInstitute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chi-Un Choe *Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bernhard H Rauch *Department of Pharmacology and Toxicology, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Edzard Schwedhelm *Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. schwedhelm@uke.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with overt cerebral ischemia are at risk for adverse events after hospital discharge. Sphingosine-1-phosphate is a potent lipid mediator produced and secreted by platelets, which is inhibited via acetylsalicylic acid (ASA). The associations of sphingosine-1-phosphate with biomarkers of platelet activation, i.e., thromboxane B

Indexed as

AspirinBrain IschemiaIschemic Attack, TransientIschemic StrokeLysophospholipidsPlatelet Aggregation InhibitorsP-SelectinSphingosineAgedBiomarkersCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective StudiesAspirinBiomarkersLysophospholipidsPlatelet Aggregation InhibitorsP-SelectinSELP protein, humanSphingosinesphingosine 1-phosphateThromboxane B2Acetylsalicylic acidAntiplatelet drugsAspirinMARK-STROKEStroke/prevention

Identifiers

PMID41060389
PMCPMC12935708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.